Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dental plaque biofilm matrix and cariogenic bacterial adhesion sites constitute a complex, multi-component structural framework essential for the survival and pathogenicity of oral microorganisms. The matrix is primarily composed of extracellular polymeric substances (EPS), including insoluble glucans synthesized by bacterial glucosyltransferases (GTFs), which provide mechanical stability and protection against host immune responses and antimicrobial agents (Bowen & Koo, 2011, Caries Research). Cariogenic bacterial adhesion sites involve specific biochemical interactions between bacterial surface adhesins, such as Antigen I/II, and the acquired pellicle—a thin layer of salivary proteins deposited on the tooth surface (Koo et al., 2013, Journal of Dental Research). This environment facilitates the localized accumulation of organic acids produced during carbohydrate fermentation, which leads to the demineralization of dental enamel and the subsequent development of dental caries (Marsh, 2004, Caries Research). Therapeutic interventions target this system by inhibiting EPS synthesis, disrupting the matrix integrity with enzymes like dextranase, or preventing initial bacterial attachment using anti-adhesive agents (Flemming & Wingender, 2010, Nature Reviews Microbiology). Understanding these sites is crucial for developing precision therapies that reduce biofilm virulence without broadly disrupting the commensal oral microbiota.
Inhibition of glucosyltransferase (GTF) enzymes to prevent the synthesis of extracellular polymeric substances (EPS), enzymatic degradation of existing matrix polysaccharides (glucans and fructans), and competitive inhibition of bacterial surface adhesins (e.g., Antigen I/II) binding to the salivary acquired pellicle.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dental plaque biofilm matrix and cariogenic bacterial adhesion sites (EPS matrix).